Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Penumbra Inc (PEN)

Penumbra Inc (PEN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,712,601
  • Shares Outstanding, K 36,482
  • Annual Sales, $ 560,410 K
  • Annual Income, $ -15,700 K
  • 60-Month Beta 0.31
  • Price/Sales 17.21
  • Price/Cash Flow 495.45
  • Price/Book 14.83
Trade PEN with:

Options Overview

Details
  • Implied Volatility 49.29%
  • Historical Volatility 23.54%
  • IV Percentile 37%
  • IV Rank 26.90%
  • IV High 93.47% on 01/29/21
  • IV Low 33.04% on 08/21/20
  • Put/Call Vol Ratio 0.13
  • Today's Volume 9
  • Volume Avg (30-Day) 84
  • Put/Call OI Ratio 1.13
  • Today's Open Interest 4,089
  • Open Int (30-Day) 5,389

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate 0.19
  • Number of Estimates 2
  • High Estimate 0.19
  • Low Estimate 0.18
  • Prior Year -0.30
  • Growth Rate Est. (year over year) +163.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
248.51 +5.50%
on 07/16/21
279.35 -6.15%
on 07/07/21
-11.36 (-4.15%)
since 07/02/21
3-Month
232.29 +12.86%
on 05/17/21
320.00 -18.07%
on 05/05/21
-35.93 (-12.05%)
since 05/03/21
52-Week
163.49 +60.36%
on 12/16/20
320.00 -18.07%
on 05/05/21
+32.69 (+14.25%)
since 08/03/20

Most Recent Stories

More News
Neurovascular Intervention Devices Market to Make Great Impact in Near Future

The global size is expected to reach USD 4.11 billion by 2027

ABT : 122.12 (+0.99%)
BSX : 45.54 (-0.74%)
PEN : 262.17 (-1.18%)
TRUMF : 39.9000 (-0.57%)
Penumbra (PEN) Earnings Expected to Grow: Should You Buy?

Penumbra (PEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PEN : 262.17 (-1.18%)
Neurothrombectomy Devices Market 2021 report explores the future trends, top companies development and forecasts

The global size is expected to reach USD 1,086.7 million by 2028 according to a new study by . Worldwide Neurothrombectomy Devices Market Analysis, 2021 research report portrays a profound plunge of market...

PEN : 262.17 (-1.18%)
SYK : 268.01 (-0.76%)
Penumbra, Inc. to Present at the Canaccord Genuity 41st Annual Growth Conference

/PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Canaccord Genuity 41st Annual Growth Conference on .

PEN : 262.17 (-1.18%)
Penumbra, Inc. Schedules Second Quarter 2021 Earnings Release and Conference Call for August 9, 2021

/PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the second quarter 2021 after market close on at 4:30 PM Eastern Time....

PEN : 262.17 (-1.18%)
Proactive news headlines including Buru Energy, Cobalt Blue Holdings, Technology Metals Australia and Theta Gold Mines

Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:

BRNGF : 0.1109 (-10.56%)
BUD : 62.51 (-0.70%)
COB : 14.10 (+0.36%)
CBBHF : 0.2178 (+1.30%)
COH : 39.90 (-0.94%)
TGMGF : 0.1690 (+25.19%)
PXS : 0.7298 (-0.71%)
BTC : 99.11 (-0.04%)
GBR : 4.55 (+2.48%)
AME : 138.77 (+0.39%)
PEN : 262.17 (-1.18%)
PENMF : 0.1200 (+3.81%)
LIT : 81.83 (-1.86%)
LMMFF : 0.1700 (+70.00%)
ESGFF : 0.1000 (-39.39%)
CCZ : 60.91 (-1.03%)
CCZ.LN : 2.025 (-1.22%)
PDI : 28.73 (+0.63%)
Alio Raises $20M in Series B Financing

/PRNewswire/ -- Alio Medical, a wearable technology company enabling greater insights through clinical grade real-time data, announced the close of a Series B financing round totaling . This round includes...

PEN : 262.17 (-1.18%)
Penumbra (PEN) Gets FDA Nod for RED 62, Grows Thrombectomy Line

Penumbra (PEN) to initiate commercialization of RED 62 Reperfusion Catheter post FDA clearance.

ISRG : 999.61 (+0.71%)
IDXX : 695.67 (+2.50%)
PEN : 262.17 (-1.18%)
PETQ : 35.31 (-1.15%)
Penumbra Receives FDA Clearance for RED 62 Reperfusion Catheter, Enabling Physicians to Address Broad Range of Stroke Patients

Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance and commercial availability of the RED(TM)...

PEN : 262.17 (-1.18%)
Proactive news headlines including Aeris Resources, Blackstone Minerals, Peninsula Energy and Latitude Consolidated

Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:

ARSRF : 0.1000 (unch)
HLX : 4.22 (+3.18%)
PGM : 49.35 (-0.41%)
PTNUF : 0.0610 (+3.39%)
BSX : 45.54 (-0.74%)
BLSTF : 0.3427 (-0.67%)
CDR : 16.62 (-0.48%)
PEN : 262.17 (-1.18%)
PENMF : 0.1200 (+3.81%)
RLTOF : 0.0150 (unch)
WRMCF : 0.3521 (+0.60%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access...

See More

Key Turning Points

3rd Resistance Point 270.61
2nd Resistance Point 268.32
1st Resistance Point 265.25
Last Price 262.17
1st Support Level 259.89
2nd Support Level 257.60
3rd Support Level 254.53

See More

52-Week High 320.00
Last Price 262.17
Fibonacci 61.8% 260.21
Fibonacci 50% 241.74
Fibonacci 38.2% 223.28
52-Week Low 163.49

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar